Progenics Pharmaceuticals
(PGNX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2013 | 09-2013 | 06-2013 | 03-2013 | 12-2012 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -42,572 | -34,021 | -23,521 | -11,258 | -35,431 |
| Depreciation Amortization | 1,858 | 774 | 595 | 277 | 1,324 |
| Income taxes - deferred | -362 | 0 | N/A | N/A | N/A |
| Accounts receivable | 4,114 | 6,240 | 5,744 | 5,402 | -5,421 |
| Other Working Capital | 1,419 | 3,720 | 3,105 | 4,756 | -6,746 |
| Other Operating Activity | -564 | -3,123 | -3,386 | -4,728 | 11,630 |
| Operating Cash Flow | $-36,107 | $-26,410 | $-17,463 | $-5,551 | $-34,644 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | 37 | 76 | 57 | 51 | -377 |
| Net Acquisitions | 1,888 | 1,888 | 1,888 | 1,888 | N/A |
| Sale Of Investment | 1,100 | 1,100 | 1,100 | 100 | 100 |
| Investing Cash Flow | $3,025 | $3,064 | $3,045 | $2,039 | $-277 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 40,149 | 40,150 | 34,846 | 3 | 23,654 |
| Other Financing Activity | -45 | -45 | -45 | -45 | 0 |
| Financing Cash Flow | $40,104 | $40,105 | $34,801 | $-42 | $23,654 |
| Beginning Cash Position | 58,838 | 58,838 | 58,838 | 58,838 | 70,105 |
| End Cash Position | 65,860 | 75,597 | 79,221 | 55,284 | 58,838 |
| Net Cash Flow | $7,022 | $16,759 | $20,383 | $-3,554 | $-11,267 |
| Free Cash Flow | |||||
| Operating Cash Flow | -36,107 | -26,410 | -17,463 | -5,551 | -34,644 |
| Capital Expenditure | -137 | -77 | -47 | -35 | -767 |
| Free Cash Flow | -36,244 | -26,487 | -17,510 | -5,586 | -35,411 |